+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hepatorenal Drug"

Hepatorenal Syndrome Treatment Market by Treatment Type, Patient Severity, Route of Administration, End User, Distribution Channel, Product Type - Global Forecast to 2030 - Product Thumbnail Image

Hepatorenal Syndrome Treatment Market by Treatment Type, Patient Severity, Route of Administration, End User, Distribution Channel, Product Type - Global Forecast to 2030

  • Report
  • May 2025
  • 185 Pages
  • Global
From
Hepatorenal Syndrome Treatment Market Report 2025 - Product Thumbnail Image

Hepatorenal Syndrome Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Hepatorenal Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatorenal Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hepatorenal Syndrome - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Hepatorenal Syndrome - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Hepatorenal Syndrome (HRS) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hepatorenal Syndrome (HRS) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hepatorenal Syndrome Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Hepatorenal Syndrome Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 110 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

The Hepatorenal Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. It focuses on drugs used to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including cirrhosis, hepatitis, nephrotic syndrome, and renal failure. They can also be used to reduce the risk of complications from liver and kidney diseases. Common drugs in this market include antivirals, immunosuppressants, diuretics, and antifibrotics. The Hepatorenal Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in this market include AbbVie, Bristol-Myers Squibb, Gilead Sciences, Merck, and Pfizer. Other companies include AstraZeneca, Bayer, Novartis, and Sanofi. Show Less Read more